Omega – 3 Fatty Acids as Pharmacotherapeutics in Psoriasis: Current Status and Scope of Nanomedicine in its Effective Delivery

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|14|6|708-722

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.6, 2013-01, pp. : 708-722

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmaconutrition with Omega-3 Fatty Acids: Status Quo and Further Perspectives

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 2, 2008-02 ,pp. : 107-115

Bentham Science Publishers

Access to resources Recommend Favorite

Omega-3 Fatty Acids in the Treatment of Psychiatric Disorders

By Peet Malcolm   Stokes Caroline  

Drugs, Vol. 65, Iss. 8, 2005-01 ,pp. : 1051-1059

Adis International

Access to resources Recommend Favorite

Omega-3 Fatty Acids and Hippocampal Neurogenesis in Depression

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 4, 2013-06 ,pp. : 460-465

Bentham Science Publishers

Access to resources Recommend Favorite

The Impact of Omega-3 Fatty Acids on Osteoporosis

By  

Current Pharmaceutical Design, Vol. 15, Iss. 36, 2009-12 ,pp. : 4157-4164

Bentham Science Publishers

Access to resources Recommend Favorite

Omega-3 Fatty Acids in the Management of Epilepsy

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 17, 2016-07 ,pp. : 1897-1905

Bentham Science Publishers

Access to resources Recommend Favorite